Latest Breaking News On - Peter hillmen - Page 1 : comparemela.com

Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard-of-Care Regimen for Previously Unmanaged CLL

The MRD-guided treatment approach has a significant advantage over chemotherapy.

United kingdomUnited statesSan diegoLeeds teaching hospitals national health serviceInternational workshop on chronic lymphocytic leukemiaUniversity of leedsAmerican society of hematology annual meeting expositionJanssen biotechPeter hillmenAmerican societyHematology annual meetingInternational workshopChronic lymphocytic leukemia

ASH recap: Transformative advance in sickle cell disease, breakthrough in AML and ALL

ASH recap: Transformative advance in sickle cell disease, breakthrough in AML and ALL
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Julie kanterJamesr berensonEmicizumab hemlibraIbrahimt aldossBymark leiserMikkaela sekeresAlexis thompsonSaadz usmaniCynthiae dunbarJoshua brodyMariaj fernandez turizoMindy valcarcelSyndax pharmaceuticalsIncyte syndax pharmaceuticalsBluebird bioPeter hillmen

Remarkable results could change the way we treat leukaemia

Remarkable results could change the way we treat leukaemia
thenewdaily.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewdaily.com.au Daily Mail and Mail on Sunday newspapers.

United kingdomIain foulkesUniversity of leedsCancer research united kingdomUniversity of leed school medicineLeed schoolNew england journalPeter hillmenExperimental haematologyExecutive director

Personalized treatment for leukemia results in longer life and fewer side effects

Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase III trial has found.

United kingdomSan diegoUnited statesIain foulkesDavid cairnsUniversity of leed school medicineLeeds cancer research united kingdomAmerican society of hematologyUniversity of leedsCancer research united kingdomJanssen research developmentAbbvie pharmaceutical researchNew england journalAmerican societyAnnual meetingJanssen research

New personalized therapy improves survival for patients with CLL leukemia, phase 3 trial finds

New personalized therapy improves survival for patients with CLL leukemia, phase 3 trial finds
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan diegoDavid cairnsIain foulkesTalha munirUniversity of leed school medicineCancer research united kingdomUniversity of leedsAmerican society of hematologyLeeds cancer research united kingdomNew england journalAmerican societyAnnual meetingPeter hillmenExperimental hematology